Makoto Haino

Title: The Innovations of Makoto Haino

Introduction

Makoto Haino is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. His work has led to the filing of multiple patents, showcasing his innovative approach to medicinal chemistry.

Latest Patents

Haino holds two recent patents that highlight his expertise. The first patent is for an N-hydroxyformamide derivative and a medicament containing the same. This compound exhibits ADAM17 inhibitory activity, which is crucial for various therapeutic applications. The second patent focuses on reverse hydroxamic acid derivatives, which possess TNF-α converting enzyme (TACE) inhibitory activity. These compounds are represented by specific general formulas that detail their structural components and potential uses in medicine.

Career Highlights

Makoto Haino is currently associated with Kaken Pharmaceutical Company, Ltd., where he continues to advance his research and development efforts. His work at Kaken has allowed him to explore innovative solutions in the pharmaceutical industry, contributing to the company's mission of improving health outcomes.

Collaborations

Haino has collaborated with esteemed colleagues such as Masanao Shimano and Noriyuki Kamei. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking innovations in the field.

Conclusion

Makoto Haino's contributions to pharmaceutical innovation are noteworthy, with his patents reflecting a commitment to advancing medical science. His work continues to impact the industry positively, paving the way for future developments in therapeutic compounds.